The Evaluation Of Inflammatory Bowel Disease Cases In Dicle University Medical Faculty Hospital Between 1999 And 2005

Abstract

Aim: Inflammatory bowel disease (IBD) is a chronic gas trointestinal illness including ulcerative colitis (UC) and Crohn’s disease (CD). In this study, we aimed to investigate social–demographic and clinical features and management strategies in patients diagnosed as IBD between 1999-2005. Material and Method: We investigated the patients examined in Gastroenterology Clinic of Dicle University Faculty of Medicine in 1999-2005, retrospectively. Mean ages, female/male ratios, smoking, types of the diseases, localizations of the disease were determined. Local or systemic complications, treatment strategies and causes of surgical treatments were evaluated. Result: A total of 42 patients diagnosed as IBD, of which 36 were UC, 6 were CD (p

Keywords

• Inflammatory bowel disease,ulcerative colitis,Crohn disease,epidemiology

Dicle Üniversitesi Tip Fakültesi Hastanesinde 1999-2005 Yillari Arasindaki Inflamatuvar Barsak Hastalikli Olgularinin Degerlendirilmesi

Abstract

Amaç: Inflamatuar barsak hastaligi (IBH), ülseratif kolit (ÜK) ve Crohn hastaligi (CH)’ni içeren gastrointestinal kanalin kronik inflamatuar bir hastaligidir. Bu çalismada, 1999-2005 yillari arasinda IBH tanisi alan hastalarin sosyodemografik özellikleri ve klinik özellikleri ile verilen tedavilerin incelenmesi amaçlandi. Gereç ve Yöntem: 1999-2005 yillari arasinda Dicle Üniversitesi Tip Fakültesi Gastroenteroloji Klinigi’ne basvuran IBH tanisi alan hastalar retrospektif olarak incelendi. Hastalarin yas ortalamasi, kadin-erkek orani, sigara kullanimi, hastaligin tipi, hastaligin yerlesim yeri tespit edildi. Hastalarda gelisen lokal ve sistemik komplikasyonlar, uygulanan tedavi tipleri ve cerrahi tedavi nedenleri degerlendirildi. Bulgular: Inflamatuar barsak hastaligi tanisi alan 42 hastadan; 36’si ÜK, 6’si CH idi (p

Keywords

• Inflamatuar barsak hastaligi,ü lseratif kolit,Crohn hastaligi,epidemiyoloji

References

1. Stenson WF: Inflammatory bowel disease. In Goldman L, Ausiello D (eds): Cecil textbook of medicine, 22nd edition.861- 868,2004.
2. Loftus EV, Sandborn WJ: Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 31:1-20, 2002.
3. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 324:84-88, 1991.
4. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut. 29:990-996, 1988.
5. Freidman S, Blumberg RS. Inflammatory bowel disease. Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL:Harrison’s internal Copright © 2005 by The McGraw-Hill Companies, Inc.1776-1789, 2005.
6. Tsianos EV, Masalas CN, Merkouropoulos M, et al. Incidence of inflammatory bowel disease in North West Greece: rarity of Crohn's disease in an area where ulcerative colitis is common. Gut.35(3):369-372,1994.
7. Shivananda S, Lennard-Jones J, Logan R.The EC-IBD Study Group, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut.39:690–697,1996.
8. Basar Ö, Ertugrul I, Ibis M, ve ark. Inflamatuvar Barsak Hastaliklarinda Ortalama Trombosit Hacmi Ölçümünün Hastalik Aktivitesi ile Iliskisi. Yeni Tip Dergisi. 2: 46-49, 2000.

9. Isbister WH, Hubler M. Inflammatory bowel disease in Saudi Arabia: presentation and initial management. J Gastroenterol Hepatol.13(11):1119-1124, 1998.
10. Tsironi E, Feakins RM, probert CS, et al. Incidence of Inflammatory Bowel Disease is Rising and Abdominal Tuberculosis is Falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol. 99:1749-1755,2004.
11. Garrido A, Martinez MJ, Ortega JA, et al. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig.96:687-691; 691-694, 2004.
12. Su CG, Judge TA, Lichtenstein GR: Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 31:307-327, 2002.
13. Özdil S, Akyüz F, Pinarbasi B, Demir K: Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepatogastroenterology. 51:768-770, 2004.
14. Archimandritis AJ, Kourtesas D, Sougioultzis S, et al. Inflammatory bowel disease in Greece – a hospital based clinical study of 172 consecutive patients. Med Sci Monit. 8:158-164, 2002.
15. Christodoulou DK, Katsanos KH, Kitsanou M, et al. Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis. 34:781-786,2002.
16. Geyik MF, Kökoglu ÖF, Hosoglu S, Ayaz C. Brusellozlu 154 hastanin degerlendirilmesi. Dicle Tip dergisi 29: 23- 29, 2002
17. Saglik Bakanligi Temel Saglik Hizmetleri Genel Müdürlügü Çalisma yilligi. Tablo 58: 130, 2000
18. Podolsky DK: Inflammatory bowel disease. N Engl J Med. 347:417-429, 2002.
19. Martins NB, Peppercorn MA: Inflammatory Bowel Disease. Am J Manag Care. 10(8):544-552,2004.
20. Sachar DB: Indications for surgery in inflammatory bowel disease: a gastroenterologist's opinion. In: Kirsner JB, ed. Inflammatory Bowel Disease. 5th ed. Philadelphia, Pa: WB Saunders Co; 611- 615, 2000.
21. Strong S, Fazio V: The surgical management of Crohn's disease. In: Kirsner JB, ed. Inflammatory Bowel Disease. 5th ed. Philadelphia, Pa: WB Saunders Co; 658-709,2000.
22. Sands BE: Therapy of inflammatory bowel disease. Gastroenterology. 118:68-82, 2000.